by North Woods | May 6, 2026 | Blog, Firm News
MADISON, Wis., May 6, 2026 — Venture Investors Health Fund, one of the Midwest’s longest-standing healthcare-focused venture firms, today announced its rebrand to Clarevia Ventures, a new name that reflects the firm’s sharpened focus on helping early-stage medtech and...
by North Woods | Mar 24, 2026 | Blog, Perspectives
By Jenni Le, Principal, Clarevia A patient suspected of sleep apnea used to spend the night in a lab, hooked up to sensors, trying to sleep in an unfamiliar environment, often producing a poor representation of a typical night. Today, that same patient can sleep in...
by North Woods | Mar 4, 2026 | Blog, Perspectives
By Paul Weiss, PhD, Partner at Clarevia In breast cancer, there was a moment when outcomes changed dramatically, but only for certain patients. Herceptin, an antibody therapy, was developed to target an overexpression of the HER2 protein. If a patient was...
by North Woods | Jan 20, 2026 | Blog, Portfolio Spotlights
For millions of people living with glaucoma, treatment often begins with a familiar daily routine: prescription eye drops lined up on the bathroom counter, reminders taped to mirrors, and the quiet worry that missing a dose could allow the disease to progress. As...
by North Woods | Dec 15, 2025 | Blog, Portfolio Spotlights
For many families, the journey to an autism diagnosis begins with a quiet worry—a toddler who isn’t talking yet, a pediatrician who shares their concern, and then a waitlist that stretches six, twelve, sometimes even twenty-four months. In that time, the most powerful...
by North Woods | Dec 2, 2025 | Blog, Portfolio Spotlights
The untold story behind HistoSonics and the collisions that drive true medical breakthroughs By Dr. Joe Amaral, Chief Medical and Scientific Officer at Clarevia Innovation rarely happens in a straight line. It’s a story of collisions—between people, ideas, timing, and...
